Kanabo Group (LSE:KNB) Research & Development: £0.28 Mil (TTM As of Jun. 2024)


What is Kanabo Group Research & Development?

Kanabo Group LSE:KNB Research & Development is £0.28 Mil as of Jun. 2024.

Research & Development is the aggregate amount of research and development expenses during the year. Kanabo Group's Research & Development for the six months ended in Jun. 2024 was £0.14 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was £0.28 Mil.

Kanabo Group  (LSE:KNB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kanabo Group Research & Development Related Terms

Kanabo Group Research & Development Historical Data

* Premium members only.

The historical data trend for Kanabo Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kanabo Group Research & Development Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 0.00 0.17 0.26 0.64 0.38

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.46 0.24 0.14 0.14

Kanabo Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.28 Mil mean?
Kanabo Group (LSE:KNB) has a Research & Development of £0.28 Mil as of Jun. 2024. Research and development expense is the total cost for research and development activities. View historical data on Kanabo Group and its competitors.
Is Kanabo Group's Research & Development too high?
Kanabo Group's current Research & Development is £0.28 Mil.
How does Kanabo Group's Research & Development compare to HCA and THC?
Kanabo Group's Research & Development of £0.28 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kanabo Group and its competitors. Kanabo Group's current Research & Development is £0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanabo Group stock overvalued right now?
Kanabo Group (LSE:KNB) has a current Research & Development of £0.28 Mil. The current Research & Development is £0.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kanabo Group (LSE:KNB), the current Research & Development is £0.28 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kanabo Group Business Description

Address 137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.